How does COVID-19 impact intrafamilial child sexual abuse? Comparison analysis of reports by practitioners in Israel and the US.


Journal

Child abuse & neglect
ISSN: 1873-7757
Titre abrégé: Child Abuse Negl
Pays: England
ID NLM: 7801702

Informations de publication

Date de publication:
06 2021
Historique:
received: 24 07 2020
revised: 13 10 2020
accepted: 13 10 2020
pubmed: 5 11 2020
medline: 8 7 2021
entrez: 4 11 2020
Statut: ppublish

Résumé

There is consensus in child sexual abuse (CSA) literature that intrafamilial child sexual abuse (IFCSA) has a tremendous impact on children and families while simultaneously creating challenges for practitioners. COVID-19 impacted countries worldwide and generated a global crisis resulting in impacts on daily life, however, it's effect on IFCSA is unknown. This study aimed to compare professional perspectives and experiences working with IFCSA with respect to the context of the COVID-19 pandemic within the United States and Israel. Participants were therapeutic, child welfare and legal professionals, who provided services to children involved in IFCSA. This qualitative cross-cultural comparative study analyzes professional experiences of IFCSA during COVID-19 based on an open-ended questionnaire answered online, with 37 responses from the US and 23 responses from Israel. Findings reveal mostly negative changes in the dynamics of IFCSA families during COVID-19, including financial, environmental, and emotional hardships, as well as some positive changes in the relationships among family members. In terms of professional interventions, concerns were raised that COVID-19 has been detrimental to the disclosure of IFCSA, with plummeting child abuse reports. Further, risk and benefits of transferring to internet based or telephonic therapeutic interventions were shared. Governmental and community efforts are needed to develop a safety net of protective factors to reduce IFCSA risks and increase resiliency during the COVID-19 pandemic and future global crises. Moreover, enhanced strategies to accessing and supporting families remotely such as using technology could improve identification and response to IFCSA.

Sections du résumé

BACKGROUND
There is consensus in child sexual abuse (CSA) literature that intrafamilial child sexual abuse (IFCSA) has a tremendous impact on children and families while simultaneously creating challenges for practitioners. COVID-19 impacted countries worldwide and generated a global crisis resulting in impacts on daily life, however, it's effect on IFCSA is unknown.
OBJECTIVE
This study aimed to compare professional perspectives and experiences working with IFCSA with respect to the context of the COVID-19 pandemic within the United States and Israel.
PARTICIPANTS AND SETTING
Participants were therapeutic, child welfare and legal professionals, who provided services to children involved in IFCSA.
METHODS
This qualitative cross-cultural comparative study analyzes professional experiences of IFCSA during COVID-19 based on an open-ended questionnaire answered online, with 37 responses from the US and 23 responses from Israel.
RESULTS
Findings reveal mostly negative changes in the dynamics of IFCSA families during COVID-19, including financial, environmental, and emotional hardships, as well as some positive changes in the relationships among family members. In terms of professional interventions, concerns were raised that COVID-19 has been detrimental to the disclosure of IFCSA, with plummeting child abuse reports. Further, risk and benefits of transferring to internet based or telephonic therapeutic interventions were shared.
CONCLUSIONS
Governmental and community efforts are needed to develop a safety net of protective factors to reduce IFCSA risks and increase resiliency during the COVID-19 pandemic and future global crises. Moreover, enhanced strategies to accessing and supporting families remotely such as using technology could improve identification and response to IFCSA.

Identifiants

pubmed: 33143870
pii: S0145-2134(20)30434-8
doi: 10.1016/j.chiabu.2020.104779
pmc: PMC7572107
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104779

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Dafna Tener (D)

Hebrew University of Jerusalem, Tel Aviv University, Mission Kids Child Advocacy Center, Montgomery County, Pennsylvania, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. Electronic address: dtener@gmail.com.

Amitai Marmor (A)

Hebrew University of Jerusalem, Tel Aviv University, Mission Kids Child Advocacy Center, Montgomery County, Pennsylvania, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Carmit Katz (C)

Hebrew University of Jerusalem, Tel Aviv University, Mission Kids Child Advocacy Center, Montgomery County, Pennsylvania, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Abbie Newman (A)

Hebrew University of Jerusalem, Tel Aviv University, Mission Kids Child Advocacy Center, Montgomery County, Pennsylvania, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Jane F Silovsky (JF)

Hebrew University of Jerusalem, Tel Aviv University, Mission Kids Child Advocacy Center, Montgomery County, Pennsylvania, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Jennifer Shields (J)

Hebrew University of Jerusalem, Tel Aviv University, Mission Kids Child Advocacy Center, Montgomery County, Pennsylvania, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Erin Taylor (E)

Hebrew University of Jerusalem, Tel Aviv University, Mission Kids Child Advocacy Center, Montgomery County, Pennsylvania, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH